KU ASH 2018 Review: Current Updates in Hematologic Diseases

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

KU ASH 2018 Review: Current Updates in Hematologic Diseases

Videos
Events

Playback speed

10 seconds

ASH December 2018 - Benign Hematolgy - Analysis of Top Trials

By KU ASH 2018 Review: Current Updates in Hematologic Diseases FEATURING Penelope Harris

547 views

March 8, 2019

Comments 0

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Videos

ASH December 2018 - MDS - Top Trials and Key Takeaways

KU ASH 2018 Review: Current Updates in Hematologic Diseases

B. Skikne

147 views

ASH December 2018 - MPN - Review and Synthesis of Recent Trials

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Yacoub

105 views

ASH 2018 Myeloid Neoplasms - How Recent Trials on Stem Cell Transpla…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Singh

238 views

ASH December 2018 - Benign Hematolgy - Analysis of Top Trials

KU ASH 2018 Review: Current Updates in Hematologic Diseases

P. Harris

547 views

ASH December 2018 - CLL and Indolent Lymphoma - Review of Clinical T…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

M. Hoffmann

569 views

ASH December 2018- Aggressive Lymphomas: Recent Approvals and Promis…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Vallurupalli

150 views

MM - Overview of Trials Presented at ASH 2018

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Abdallah

1.3K views

ASH December 2018 - Lymphoma- Historical Perspective of CAR-T Cell T…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

210 views

ASH December 2018- Lymphoma - Efficacy and Safety from ZUMA 1, JULIE…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

380 views

ASH December 2018 - Lymphoma - Axi-cel as Standard of Care and Relat…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

200 views

ASH December 2018 - Myeloma - BCMA CAR T Therapy for Refractory Pati…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

242 views

ASH 2018 AML: Deciding Between Standard vs Investigational Therapies…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

571 views

ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Re…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

197 views

ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantat…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

42 views

ASH 2018 AML Challenges in Evaluating New Therapies: Understanding t…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

181 views

06:55

KU ASH 2018 Review: Current Updates in Hematologic Diseases

Lymphoma and Myeloma - Cellular Therapy, Efficacy and Safety from Top Tria…

Feat. F. Locke

23:37

KU ASH 2018 Review: Current Updates in Hematologic Diseases

AML - Keynote - Latest updates on Standard Therapies and Investigati…

Feat. E. Estey